GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (CHIX:DIMp) » Definitions » Change In Other Working Capital

Sartorius Stedim Biotech (CHIX:DIMP) Change In Other Working Capital : €55 Mil (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sartorius Stedim Biotech Change In Other Working Capital?

Sartorius Stedim Biotech's Change In Other Working Capital for the quarter that ended in Sep. 2024 was €22 Mil. It means Sartorius Stedim Biotech's Other Working Capital increased by €22 Mil from Jun. 2024 to Sep. 2024 .

Sartorius Stedim Biotech's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €-103 Mil. It means Sartorius Stedim Biotech's Other Working Capital declined by €103 Mil from Dec. 2022 to Dec. 2023 .

Sartorius Stedim Biotech Change In Other Working Capital Historical Data

The historical data trend for Sartorius Stedim Biotech's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Change In Other Working Capital Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.94 146.91 217.00 -67.60 -102.60

Sartorius Stedim Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.10 -109.60 33.80 - 21.60

Sartorius Stedim Biotech Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (CHIX:DIMp) » Definitions » Change In Other Working Capital
Comparable Companies
XPAR:AMPLI XPAR:ALCJ XPAR:ALKLH XPAR:MLBON XPAR:ALSPW XPAR:ALICR ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO XSWX:STMN HOLX TSE:7733 BAX
Traded in Other Exchanges
SRTOY:USA SDMHF:USA 0RG8:UK DIM:France 56S1:Germany DIM:Austria
Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Website
https://www.sartorius.com
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech Headlines

No Headlines